Queen Silvia Children's Hospital, Gothenburg, Sweden Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2013
NCT02760472
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

clinoleic (1 trial)

smoflipid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Premature Birth (Phase 3)

Retinal Diseases (Phase 3)

Retinopathy of Prematurity (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2